Thrombolysis in Stroke Mimics: Brain Tumors
<p id="p1">Stroke is a clinical syndrome characterized by a sudden-onset neurological deficit of vascular etiology and is a major cause of mortality and morbidity worldwide. Stroke-like clinical symptoms that are later found to have nonvascular disorders have been termed stroke mimics. Its incidence...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/89793 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p id="p1">Stroke is a clinical syndrome characterized by a sudden-onset neurological deficit of vascular etiology and is a major cause of mortality and morbidity worldwide. Stroke-like clinical symptoms that are later found to have nonvascular disorders have been termed stroke mimics. Its incidence ranges from 1.3–25%. The use of thrombolytics in ischemic stroke has an undeniable benefit when applied in the correct time window. However, cerebral hemorrhage is the most feared complication of thrombolytic use and is a relevant cause of morbidity and mortality. Eventually, intravenous thrombolysis of stroke mimics may occur. In this chapter, we will discuss the incidence, management, and outcome of thrombolysis in stroke mimics, with an emphasis on patients with brain tumors.</p> |
|---|---|
| ISBN: | 978-0-85014-468-0 |
| DOI: | 10.5772/intechopen.115616 |